A “Protease Activation Cascade” in the Pathogenesis of Alzheimer's Disease

Abstract: A pathway to Alzheimer's disease (AD) relevant to sporadic AD pathogenesis is described that involves the early and progressive activation of proteolytic systems including, but not limited to, the calpain‐calpastatin and endosomal‐lysosomal systems. Activation of these proteolytic systems is initiated by normal brain aging and is propelled by the genetic and environmental factors known to increase AD risk. Recent studies show how cathepsins and calpains, acting directly or indirectly through other proteolytic pathways and cellular signaling cascades, may promote β‐amyloidogenesis, neurofibrillary pathology, as well as mediate neurodegeneration in AD.

[1]  A. Olsson,et al.  Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[2]  T. Yamashima,et al.  Postictal Blockade of Ischemic Hippocampal Neuronal Death in Primates Using Selective Cathepsin Inhibitors , 1999, Experimental Neurology.

[3]  D. Kessel,et al.  Determinants of the Apoptotic Response to Lysosomal Photodamage , 2000, Photochemistry and photobiology.

[4]  W. Schneider-Brachert,et al.  Cathepsin D targeted by acid sphingomyelinase‐derived ceramide , 1999, The EMBO journal.

[5]  S. Walkley.  Cellular Pathology of Lysosomal Storage Disorders , 1998, Brain pathology.

[6]  D. Selkoe,et al.  Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. , 1999, The Journal of biological chemistry.

[7]  P. Seglen,et al.  Non-selective autophagy. , 1990, Seminars in cell biology.

[8]  E. Fossel,et al.  Cell death induced by peroxidized low-density lipoprotein: endopepsis. , 1994, Cancer research.

[9]  J. Hardy,et al.  Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease , 1997, Neuroscience Letters.

[10]  M. Baumann,et al.  A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration , 2000, The EMBO journal.

[11]  Kevin K W Wang,et al.  Calpain and caspase: can you tell the difference?, by Kevin K.W. Wang Vol. 23, pp. 20–26 , 2000, Trends in Neurosciences.

[12]  D. Green,et al.  Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. , 1999, Blood.

[13]  A. Yang,et al.  Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1‐42 pathogenesis , 1998, Journal of neuroscience research.

[14]  D. Wunderlich,et al.  Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation. , 1994, European journal of biochemistry.

[15]  R. Nixon,et al.  Calpain I activation in rat hippocampal neurons in culture is NMDA receptor selective and not essential for excitotoxic cell death. , 1998, Brain research. Molecular brain research.

[16]  B. McVicker,et al.  Ethanol-impaired hepatic protein trafficking: concepts from the asialoglycoprotein receptor system. , 1999, Clinical biochemistry.

[17]  Kinuko Suzuki,et al.  Recent Advances in Elucidating Niemann‐Pick C Disease , 1998, Brain pathology.

[18]  G. Lynch,et al.  Increased spectrin proteolysis in fibroblasts from aged and Alzheimer donors , 1991, Neuroscience Letters.

[19]  Y. Uchiyama,et al.  Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases , 1999, Neuroscience.

[20]  M. Goedert,et al.  Cathepsin D displays in vitro beta-secretase-like specificity. , 1997, Brain research.

[21]  G. Lynch,et al.  Changes in the concentrations of tau and other structural proteins in the brains of aged mice , 1994, Neuroscience Letters.

[22]  J. Goldman,et al.  Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Nixon,et al.  Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  K. Roberg,et al.  Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. , 1999, Free radical biology & medicine.

[25]  A. Guidotti,et al.  Activation of caspase‐3 and apoptosis in cerebellar granule cells , 1998, Journal of neuroscience research.

[26]  R. Nixon,et al.  Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease , 1994, Brain Research.

[27]  T. Shearer,et al.  Lp82 is the dominant form of calpain in young mouse lens. , 1999, Experimental eye research.

[28]  T. Saido,et al.  Evidence for the involvement of calpain in cataractogenesis in Shumiya cataract rat (SCR). , 1997, Biochimica et biophysica acta.

[29]  D. Teplow,et al.  Amyloid beta-peptide is produced by cultured cells during normal metabolism. , 1992, Nature.

[30]  Kevin K. W Wang,et al.  Calpain and caspase: can you tell the difference? , 2000, Trends in Neurosciences.

[31]  U. Brunk,et al.  Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. , 1997, Free radical biology & medicine.

[32]  U. Brunk,et al.  Oxidant-induced apoptosis: a consequence of lethal lysosomal leak? , 1997, Redox report : communications in free radical research.

[33]  C. Masters,et al.  Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D. , 1995, Biochemistry.

[34]  Virginia M. Y. Lee,et al.  Expression of β-Amyloid Precursor Protein-CD3γ Chimeras to Demonstrate the Selective Generation of Amyloid β1–40and Amyloid β1–42 Peptides within Secretory and Endocytic Compartments* , 1999, The Journal of Biological Chemistry.

[35]  John Q Trojanowski,et al.  Neurodegenerative Tauopathies Human Disease and Transgenic Mouse Models , 1999, Neuron.

[36]  A. Lajtha,et al.  Changes in Brain Protease Activity in Aging , 1996, Journal of neurochemistry.

[37]  R. DeBiasi,et al.  Reovirus-Induced Apoptosis Is Preceded by Increased Cellular Calpain Activity and Is Blocked by Calpain Inhibitors , 1999, Journal of Virology.

[38]  T. Yamashima,et al.  Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA‐074: a novel strategy for neuroprotection based on ‘calpain–cathepsin hypothesis’ , 1998 .

[39]  R. Nixon,et al.  The endosomal-lysosomal system of neurons: new roles , 1995, Trends in Neurosciences.

[40]  D. Selkoe,et al.  Mutagenesis Identifies New Signals for β-Amyloid Precursor Protein Endocytosis, Turnover, and the Generation of Secreted Fragments, Including Aβ42* , 1999, The Journal of Biological Chemistry.

[41]  R. Nixon,et al.  Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis , 1997, The Journal of Neuroscience.

[42]  H. Nakanishi,et al.  Increased Expression of Cathepsins E and D in Neurons of the Aged Rat Brain and Their Colocalization with Lipofuscin and Carboxy‐Terminal Fragments of Alzheimer Amyloid Precursor Protein , 1997, Journal of neurochemistry.

[43]  T B Shea,et al.  Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Disease a , 1994, Annals of the New York Academy of Sciences.

[44]  S. Bressler,et al.  The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type , 1998, Human Genetics.

[45]  M. Jadot,et al.  Biochemical Characterization of a Lysosomal Protease Deficient in Classical Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) and Development of an Enzyme‐Based Assay for Diagnosis and Exclusion of LINCL in HUman Specimens and Animal Models , 1999, Journal of neurochemistry.

[46]  K. Öllinger,et al.  Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. , 1998, The American journal of pathology.

[47]  S. DeKosky,et al.  Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene , 1998, Neuroscience Letters.

[48]  G. Lynch,et al.  Suppression of Cathepsins B and L Causes a Proliferation of Lysosomes and the Formation of Meganeurites in Hippocampus , 1997, The Journal of Neuroscience.

[49]  Jinhe Li,et al.  Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system , 1995, Neuron.

[50]  R. Nixon,et al.  Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  L. Yang,et al.  Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments. , 1995, European journal of biochemistry.

[52]  Len A. Pennacchio,et al.  Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice , 1998, Nature Genetics.

[53]  R. Miller,et al.  Role of calpain- and interleukin-1 beta converting enzyme-like proteases in the beta-amyloid-induced death of rat hippocampal neurons in culture. , 1997, Journal of neurochemistry.

[54]  M. Takeda,et al.  Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease , 1991, Neuroscience Letters.

[55]  L. Tsai,et al.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.

[56]  I. Touitou,et al.  Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction--single strand conformational polymorphism analysis and possible consequences in cancer cells. , 1994, European journal of cancer.

[57]  Peng Li,et al.  Direct Cleavage by the Calcium-activated Protease Calpain Can Lead to Inactivation of Caspases* , 2000, The Journal of Biological Chemistry.

[58]  C. Guenet,et al.  A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease. , 1997, European journal of biochemistry.

[59]  H. Bernstein,et al.  The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review. , 1996, Molecular and chemical neuropathology.

[60]  D. Dickson,et al.  Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2. , 1987, The American journal of pathology.

[61]  K. Figura,et al.  Mannose 6‐phosphate receptor dependent secretion of lysosomal enzymes. , 1990, The EMBO journal.

[62]  T. Iwatsubo,et al.  Molecular interactions between presenilin and calpain: inhibition of m-calpain protease activity by presenilin-1, 2 and cleavage of presenilin-1 by m-, mu-calpain. , 2000, International journal of molecular medicine.

[63]  E. Bird,et al.  Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin , 1990, Brain Research.

[64]  C. Cotman,et al.  The Brain's Microenvironment, Early Functional Loss, and the Conversion to Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[65]  Y. Ihara,et al.  Anomalous accumulation of τ and ubiquitin immunoreactivities in rat brain caused by protease inhibition and by normal aging: a clue to PHF pathogenesis? , 1989, Brain Research.

[66]  D. Selkoe,et al.  Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S. , 1995, The Biochemical journal.

[67]  P. Coleman,et al.  Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. , 1999, Journal of neuropathology and experimental neurology.

[68]  R. Nixon,et al.  Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease , 1997, Brain Research.

[69]  S. Squazzo,et al.  Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.

[70]  G. Cole,et al.  Activation of Calpain I Converts Excitotoxic Neuron Death into a Caspase-independent Cell Death* , 2000, The Journal of Biological Chemistry.

[71]  R. Nixon,et al.  The Lysosomal System in Neuronal Cell Death: A Review a , 1993, Annals of the New York Academy of Sciences.

[72]  Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[73]  G. Lynch,et al.  Cytosolic Proteolysis of τ by Cathepsin D in Hippocampus Following Suppression of Cathepsins B and L , 1996, Journal of neurochemistry.

[74]  F. Jessen,et al.  Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease , 1999, Neuroscience Letters.

[75]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[76]  K. Ollinger.  Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes. , 2000, Archives of biochemistry and biophysics.

[77]  C. Martínez-A,et al.  Implication of calpain in caspase activation during B cell clonal deletion , 1999, The EMBO journal.

[78]  M. Mercken,et al.  Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF‐tau , 1995, FEBS letters.

[79]  J. Paul Robinson.  Oxidative Metabolism , 1997, Current protocols in cytometry.

[80]  R. Bartus,et al.  The Calpain Hypothesis of Neurodegeneration: Evidence for a Common Cytotoxic Pathway , 1997 .

[81]  M. Mattson.  Existing Data Suggest That Alzheimer's Disease Is Preventable , 2000, Annals of the New York Academy of Sciences.

[82]  G. Johnson,et al.  Phosphorylation of τ In Situ: Inhibition of Calcium‐Dependent Proteolysis , 1995, Journal of neurochemistry.

[83]  M. Goedert,et al.  Cathepsin D displays in vitro β-secretase-like specificity , 1997, Brain Research.

[84]  B T Hyman,et al.  Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. , 2000, The American journal of pathology.

[85]  L. Tsai,et al.  Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.

[86]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[87]  J. C. de la Torre.  Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. , 2000, Annals of the New York Academy of Sciences.

[88]  G Lynch,et al.  Novel Cathepsin D Inhibitors Block the Formation of Hyperphosphorylated Tau Fragments in Hippocampus , 2000, Journal of neurochemistry.

[89]  K. Ishiguro,et al.  Calpain-dependent Proteolytic Cleavage of the p35 Cyclin-dependent Kinase 5 Activator to p25* , 2000, The Journal of Biological Chemistry.

[90]  C. Milstein,et al.  Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[91]  P. Yuen,et al.  Calpain : pharmacology and toxicology of calcium-dependent protease , 1999 .

[92]  M. Hutton,et al.  FTDP‐17 tau mutations decrease the susceptibility of tau to calpain I digestion , 1999, FEBS letters.

[93]  A. Matus,et al.  Age-related increase in a cathepsin D like protease that degrades brain microtubule-associated proteins. , 1987, Biochemistry.

[94]  N. Katunuma,et al.  Participation of a cathepsin L-type protease in the activation of caspase-3. , 1999, Cell structure and function.

[95]  H. Langen,et al.  Identification of β-secretase-like activity using a mass spectrometry-based assay system , 2000, Nature Biotechnology.

[96]  R. Nixon,et al.  Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[97]  A. Malkinson,et al.  Calpain and calpastatin regulate neutrophil apoptosis , 1999, Journal of cellular physiology.

[98]  A. Kimchi,et al.  Cathepsin D protease mediates programmed cell death induced by interferon‐gamma, Fas/APO‐1 and TNF‐alpha. , 1996, The EMBO journal.

[99]  K. Blennow,et al.  Increased Proteolytic Activity in Erythrocytes from Patients with Alzheimer's Disease , 1992 .

[100]  Naren L. Banik,et al.  Oxidative stress and Ca2+ influx upregulate calpain and induce apoptosis in PC12 cells , 2000, Brain Research.

[101]  W. Burke,et al.  Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease , 1994, Brain Research.

[102]  H. Bernstein,et al.  Immunodetection of cathepsin D in neuritic plaques found in brains of patients with dementia of Alzheimer type. , 1989, Journal fur Hirnforschung.

[103]  B. Dastugue,et al.  [Apolipoprotein E and Alzheimer's disease]. , 1998, Annales de biologie clinique.

[104]  C. Glabe,et al.  Intracellular Aβ1-42 Aggregates Stimulate the Accumulation of Stable, Insoluble Amyloidogenic Fragments of the Amyloid Precursor Protein in Transfected Cells (*) , 1995, The Journal of Biological Chemistry.

[105]  J. Jordán,et al.  Role of Calpain‐ and Interleukin‐1β Converting Enzyme‐Like Proteases in the β‐Amyloid‐Induced Death of Rat Hippocampal Neurons in Culture , 1997 .

[106]  C. Peters,et al.  Amyloidogenic Processing of Human Amyloid Precursor Protein in Hippocampal Neurons Devoid of Cathepsin D* , 1996, The Journal of Biological Chemistry.

[107]  N. Kosower,et al.  Band 3 protein degradation by calpain is enhanced in erythrocytes of old people. , 1991, The Biochemical journal.

[108]  G. Lynch,et al.  Lysosomal Dysfunction Reduces Brain-Derived Neurotrophic Factor Expression , 1998, Experimental Neurology.

[109]  J. Carney.  Oxidative Stress Leading to Loss of Critical Proteases in Alzheimer's Disease: An Alternative View of the Etiology of AD , 2000, Annals of the New York Academy of Sciences.

[110]  R. Doms,et al.  Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells , 1997, Nature Medicine.

[111]  J. Pauls,et al.  A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease , 2000, Annals of neurology.

[112]  Steven M. Horvath,et al.  Alpha-2 macroglobulin is genetically associated with Alzheimer disease , 1998, Nature Genetics.

[113]  R. Nixon,et al.  Calcium Influx into Human Neuroblastoma Cells Induces ALZ‐50 Immunoreactivity: Involvement of Calpain‐Mediated Hydrolysis of Protein Kinase C , 1996, Journal of neurochemistry.

[114]  D. Kessel,et al.  Determinants of the Apoptotic Response to Lysosomal Photodamage , 2000, Photochemistry and photobiology.

[115]  P. Mathews,et al.  The neuronal endosomal-lysosomal system in Alzheimer's disease. , 2001, Journal of Alzheimer's disease : JAD.

[116]  B. Horecker,et al.  Biochemical responses in activated human neutrophils mediated by protein kinase C and a Ca2+-requiring proteinase. , 1986, The Journal of biological chemistry.